ATM (8.3%) was the most frequently mutated HRR gene in the Chinese SCLC patients, followed by NBN (4.5%), BARD1 (3.8%), BRCA1 (3.8%), BRCA2 (3.8%), and RAD50 (3.8%). This evidence concerns the gene BRCA1 and small cell lung carcinoma.